Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
41.7 USD | -1.92% | -12.35% | -30.50% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.50% | 5.16B | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.02% | 32.43B | |
+55.89% | 24.28B | |
-16.16% | 15.52B | |
-41.29% | 12.17B | |
-15.54% | 12.01B | |
-11.75% | 12B | |
+7.87% | 8.87B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- UBS Adjusts Apellis Pharmaceuticals Price Target to $87 From $70, Maintains Buy Rating